SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $420 | +10.2% | 10 | 0.0% | 0.00% | – |
| Q4 2022 | $381 | – | 10 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 10 | -16.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 12 | -94.1% | 0.00% | – |
| Q4 2021 | $8,000 | – | 204 | +1940.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | -80.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 50 | +316.7% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 12 | -53.8% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 26 | +44.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 18 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 18 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 18 | -47.1% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 34 | +21.4% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 28 | -56.2% | 0.00% | – |
| Q2 2016 | $2,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |